Thank you, Mark.
Investments were immediately made in a number of companies in March and April, including Medicago and AbCellera. April 25, 2020 was when there was a call-out for applications for vaccine therapeutics, as well as biomanufacturing projects that went to the strategic innovation fund.
Around 90 proposals were received, 21 of which were biomanufacturing proposals. Those proposals were evaluated rigorously with expert advice, and then funded as soon as possible thereafter for those that were deemed to be promising and successful. Those investments continue today and will continue into the future as the government looks towards the long-term pandemic preparedness and biomanufacturing strategy.